These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. HIV type 1 vaccine-induced cytotoxic T cell responses: potential role in vaccine efficacy. Ada GL; McElrath MJ AIDS Res Hum Retroviruses; 1997 Feb; 13(3):205-10. PubMed ID: 9115805 [No Abstract] [Full Text] [Related]
33. [Theory for prophylactic AIDS vaccine development]. Nomura T; Matano T Uirusu; 2009 Dec; 59(2):267-75. PubMed ID: 20218335 [TBL] [Abstract][Full Text] [Related]
34. AIDS research. Merck reemerges with a bold AIDS vaccine effort. Cohen J Science; 2001 Apr; 292(5514):24-5. PubMed ID: 11294193 [No Abstract] [Full Text] [Related]
35. A strategy for prophylactic vaccination against HIV. Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553 [No Abstract] [Full Text] [Related]
36. Toward an AIDS vaccine. Walker BD; Burton DR Science; 2008 May; 320(5877):760-4. PubMed ID: 18467582 [TBL] [Abstract][Full Text] [Related]
37. AIDS 1998. Vaccines and immunology: overview. Stott J; Hu SL AIDS; 1998; 12 Suppl A():S95-6. PubMed ID: 9632990 [No Abstract] [Full Text] [Related]
38. Quest for an effective AIDS vaccine takes a new tack. Maurice J Lancet; 2011 Jul; 378(9787):213-4. PubMed ID: 21770060 [No Abstract] [Full Text] [Related]
39. Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infection. Santra S; Barouch DH; Kuroda MJ; Schmitz JE; Krivulka GR; Beaudry K; Lord CI; Lifton MA; Wyatt LS; Moss B; Hirsch VM; Letvin NL J Virol; 2002 Jun; 76(12):6376-81. PubMed ID: 12021371 [TBL] [Abstract][Full Text] [Related]
40. Immunology in AIDS in 1990. Sela M AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]